{
  "meta": {
    "title": "20_Diuretics",
    "url": "https://brainandscalpel.vercel.app/20-diuretics-26d778e4.html",
    "scrapedAt": "2025-11-30T06:59:46.261Z"
  },
  "questions": [
    {
      "id": 85167,
      "choices": [
        {
          "id": 293785,
          "text": "Triamterene"
        },
        {
          "id": 293786,
          "text": "Spironolactone"
        },
        {
          "id": 293787,
          "text": "Indapamide"
        },
        {
          "id": 293788,
          "text": "Xipamide"
        }
      ],
      "text": "Which of the following is an inhibitor of Renal Epithelial Na+ Channels",
      "unique_key": "Q3497218",
      "question_audio": null,
      "question_video": null,
      "map_id": 34396624,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Triamterene. Explanation for the Correct Answer: Triamterene is a potassium-sparing diuretic that directly inhibits epithelial sodium channels (ENaC) in the collecting ducts of the nephron. By blocking sodium reabsorption, it prevents potassium excretion, helping to reduce potassium loss that occurs with other diuretics. Unlike aldosterone antagonists (e.g., spironolactone), triamterene works independently of aldosterone and directly inhibits sodium entry through ENaC. This leads to mild diuresis, natriuresis (sodium excretion), and potassium retention, making it useful in conditions like Liddle syndrome and as an adjunct to thiazide or loop diuretics to prevent hypokalemia. Thus, triamterene is the correct answer as an inhibitor of renal epithelial Na? channels. Explanation of Incorrect Options: (B) Spironolactone: This is incorrect because spironolactone is a mineralocorticoid (aldosterone) receptor antagonist. It does not directly block ENaC but instead reduces ENaC expression by inhibiting aldosterone’s action. While it ultimately decreases sodium reabsorption, its mechanism is indirect compared to triamterene. (C) Indapamide: This is incorrect because indapamide is a thiazide-like diuretic that acts on the distal convoluted tubule (DCT) by inhibiting the Na?/Cl? co-transporter. It does not affect ENaC in the collecting ducts. It promotes sodium and water excretion but can lead to hypokalemia instead of potassium retention. (D) Xipamide: This is incorrect because xipamide is also a thiazide-like diuretic with action similar to indapamide, inhibiting Na?/Cl? co-transport in the DCT. Like other thiazides, it does not directly inhibit ENaC. It is mainly used for hypertension and edema management.",
      "correct_choice_id": 293785,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66837031698478385/66837031698478385.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/66837031698478385/66837031698478385.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85168,
      "choices": [
        {
          "id": 293789,
          "text": "Thiazide diuretics decrease glucose tolerance"
        },
        {
          "id": 293790,
          "text": "Thiazide-induced diabetes mellitus is associated with the same cardiovascular disease risk as incident diabetes"
        },
        {
          "id": 293791,
          "text": "Hyperglycemia is due to reduced insulin secretion and alterations in glucose metabolism"
        },
        {
          "id": 293792,
          "text": "Hyperglycemia is reduced when K+ is given along with the diuretic"
        }
      ],
      "text": "Thiazide diuretics are known to cause hyperglycemia, which of the following is incorrect about it",
      "unique_key": "Q4948742",
      "question_audio": null,
      "question_video": null,
      "map_id": 34067409,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Thiazide-induced diabetes mellitus is associated with the same cardiovascular disease risk as incident diabetes. Explanation for the Correct Answer: Thiazide diuretics can induce hyperglycemia by causing hypokalemia, reduced insulin secretion, and altered glucose metabolism. However, thiazide-induced diabetes mellitus does not carry the same cardiovascular disease (CVD) risk as naturally occurring or incident diabetes. Studies suggest that while thiazide diuretics can increase blood glucose levels, their long-term cardiovascular benefits (such as lowering blood pressure and reducing heart failure risk) outweigh the potential risk of mild hyperglycemia. Unlike primary diabetes, thiazide-induced hyperglycemia is usually reversible and less likely to cause long-term microvascular or macrovascular complications. Thus, statement (B) is incorrect, making it the correct answer. Explanation of Incorrect Options: (A) Thiazide diuretics decrease glucose tolerance – Correct Statement Thiazide diuretics reduce glucose tolerance by causing hypokalemia, which impairs insulin secretion from pancreatic beta cells. Additionally, they increase insulin resistance by altering glucose metabolism. (C) Hyperglycemia is due to reduced insulin secretion and alterations in glucose metabolism – Correct Statement Thiazides cause hypokalemia, which directly affects pancreatic beta-cell function, leading to decreased insulin secretion. They also contribute to insulin resistance by altering glucose uptake in peripheral tissues, thereby increasing blood glucose levels. (D) Hyperglycemia is reduced when K+ is given along with the diuretic – Correct Statement The hypokalemia-induced impairment of insulin secretion is a key contributor to hyperglycemia with thiazides. Supplementing potassium (K+) or using potassium-sparing diuretics (e.g., amiloride, spironolactone) can help mitigate this effect and reduce the risk of thiazide-induced hyperglycemia.",
      "correct_choice_id": 293790,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85169,
      "choices": [
        {
          "id": 293793,
          "text": "Hypochloremia"
        },
        {
          "id": 293794,
          "text": "Hypermagnesemia"
        },
        {
          "id": 293795,
          "text": "Metabolic alkalosis"
        },
        {
          "id": 293796,
          "text": "Hypercalcemia"
        }
      ],
      "text": "Following fluid and electrolyte imbalance are seen with thiazide diuretics except",
      "unique_key": "Q7871113",
      "question_audio": null,
      "question_video": null,
      "map_id": 34535723,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Hypermagnesemia Explanation for the Correct Answer: Thiazide diuretics do not cause hypermagnesemia; instead, they lead to hypomagnesemia due to increased renal excretion of magnesium. Mechanism: Thiazides inhibit the Na+/Cl- symporter in the distal convoluted tubule (DCT), causing natriuresis and diuresis. This increases the excretion of magnesium and potassium, leading to hypomagnesemia and hypokalemia rather than hypermagnesemia. Since hypermagnesemia is not a known effect of thiazide diuretics, option (B) is incorrect, making it the correct answer for the question. Incorrect Options: (A) Hypochloremia Thiazides cause hypochloremia due to increased chloride excretion in the urine along with sodium. This can contribute to metabolic alkalosis because chloride loss impairs bicarbonate excretion, leading to an increased serum bicarbonate level. (C) Metabolic Alkalosis Metabolic alkalosis occurs due to increased sodium and chloride loss, which results in compensatory bicarbonate retention. Additionally, hypokalemia due to thiazides enhances hydrogen ion (H+) secretion, further worsening alkalosis. (D) Hypercalcemia Thiazide diuretics reduce calcium excretion by increasing calcium reabsorption in the distal convoluted tubule. This can lead to hypercalcemia, especially in individuals with an underlying predisposition (e.g., hyperparathyroidism). This effect is opposite to loop diuretics, which increase calcium excretion and can cause hypocalcemia.",
      "correct_choice_id": 293794,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59852161698478426/59852161698478426.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/59852161698478426/59852161698478426.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85170,
      "choices": [
        {
          "id": 293797,
          "text": "Chlorthiazide"
        },
        {
          "id": 293798,
          "text": "Indapamide"
        },
        {
          "id": 293799,
          "text": "Chlorthalidone"
        },
        {
          "id": 293800,
          "text": "Clopamide"
        }
      ],
      "text": "Which of the following diuretic is active even when GFR is less than 30-40 mL/min",
      "unique_key": "Q2218679",
      "question_audio": null,
      "question_video": null,
      "map_id": 34159741,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Indapamide Indapamide is a thiazide-like diuretic that remains effective even when glomerular filtration rate (GFR) falls below 30–40 mL/min. Unlike traditional thiazide diuretics, which lose efficacy in moderate-to-severe renal impairment, indapamide maintains its diuretic action because: It has additional vasodilatory properties, which improve renal blood flow and reduce vascular resistance. It acts on the Na+/Cl- symporter in the distal convoluted tubule, leading to natriuresis (sodium excretion). It is more lipid-soluble and has a longer half-life, allowing sustained activity even in patients with chronic kidney disease (CKD). Due to these properties, indapamide is often preferred over classical thiazides in patients with reduced GFR. Incorrect Options: (A) Chlorthiazide A classical thiazide diuretic, chlorthiazide loses effectiveness when GFR drops below 30-40 mL/min. It requires adequate renal function for sodium and chloride excretion. (C) Chlorthalidone Although long-acting and more potent than hydrochlorothiazide, it also loses effectiveness in moderate-to-severe renal impairment (GFR < 30 mL/min). Its mechanism of action remains dependent on renal function, making it unsuitable for low GFR states. (D) Clopamide A thiazide-like diuretic but not as effective as indapamide in patients with reduced renal function. Similar to chlorthalidone, it gradually loses efficacy as kidney function declines.",
      "correct_choice_id": 293798,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75752101698478456/75752101698478456.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/75752101698478456/75752101698478456.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85171,
      "choices": [
        {
          "id": 293801,
          "text": "Chlorthalidone"
        },
        {
          "id": 293802,
          "text": "Hydrochlorothiazide"
        },
        {
          "id": 293803,
          "text": "Chlorothiazide"
        },
        {
          "id": 293804,
          "text": "Indapamide"
        }
      ],
      "text": "Most potent diuretic among the following diuretics is",
      "unique_key": "Q6024580",
      "question_audio": null,
      "question_video": null,
      "map_id": 34526959,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Indapamide Indapamide is considered the most potent diuretic among the options listed because: It is a thiazide-like diuretic with a longer duration of action compared to classical thiazide diuretics. It has higher lipid solubility, allowing better tissue penetration and prolonged effect. Unlike conventional thiazides, indapamide exhibits vasodilatory effects, reducing peripheral vascular resistance and enhancing antihypertensive action. It remains effective even in moderate renal impairment (GFR < 30-40 mL/min), whereas most thiazides lose their efficacy at low GFR. Indapamide is more potent per milligram dose than hydrochlorothiazide or chlorthalidone, requiring lower doses to achieve a similar diuretic effect. Thus, indapamide is the most potent option among the given choices. Explanation of Incorrect Options: (A) Chlorthalidone – Incorrect A long-acting thiazide-like diuretic, more potent than hydrochlorothiazide and chlorothiazide, but less potent than indapamide. It has a longer half-life (40–60 hours), providing sustained diuresis and antihypertensive effects. However, it is not as effective in low GFR states as indapamide. (B) Hydrochlorothiazide – Incorrect A widely used thiazide diuretic, but less potent than chlorthalidone and indapamide. It has a shorter half-life (6–12 hours) and requires higher doses to achieve comparable effects. Loses effectiveness in renal impairment (GFR < 30-40 mL/min). (C) Chlorothiazide – Incorrect Least potent among the options, requiring higher doses (500–1000 mg) to achieve diuresis. It has a short half-life (1.5–2 hours) and is less effective compared to other thiazides. Not preferred for chronic hypertension or heart failure due to its weaker action.",
      "correct_choice_id": 293804,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85172,
      "choices": [
        {
          "id": 293805,
          "text": "Furosemide"
        },
        {
          "id": 293806,
          "text": "Acetazolamide"
        },
        {
          "id": 293807,
          "text": "Spironolactone"
        },
        {
          "id": 293808,
          "text": "Chlorthalidone"
        }
      ],
      "text": "Which of the following diuretic acts by inhibiting Na+Cl- symport",
      "unique_key": "Q5382890",
      "question_audio": null,
      "question_video": null,
      "map_id": 34513966,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Chlorthalidone Chlorthalidone is a thiazide-like diuretic that acts by inhibiting the Na+/Cl- symporter in the distal convoluted tubule (DCT) of the nephron. This mechanism leads to: Reduced sodium (Na+) and chloride (Cl-) reabsorption, causing increased excretion of sodium and water, which results in diuresis. Increased calcium (Ca2+) reabsorption, making it beneficial for conditions like nephrolithiasis and osteoporosis. Antihypertensive effects by reducing plasma volume and decreasing peripheral vascular resistance. Due to its long half-life (~40-60 hours), chlorthalidone provides more sustained diuretic and antihypertensive action compared to hydrochlorothiazide. Incorrect Options: (A) Furosemide – Incorrect Furosemide is loop diuretic, not a thiazide-like diuretic. It acts on the Na+-K+-2Cl- symporter in the thick ascending limb of the loop of Henle, causing stronger diuresis than thiazides. It does not inhibit the Na+/Cl- symporter in the DCT. (B) Acetazolamide – Incorrect Acetazolamide is a carbonic anhydrase inhibitor that acts in the proximal convoluted tubule (PCT). It inhibits carbonic anhydrase, leading to reduced bicarbonate (HCO3-) reabsorption, resulting in metabolic acidosis. It does not affect the Na+/Cl- symporter. (C) Spironolactone – Incorrect Spironolactone is a potassium-sparing diuretic that acts as an aldosterone receptor antagonist in the collecting duct. It prevents sodium reabsorption and potassium excretion by blocking aldosterone’s action. It has no effect on the Na+/Cl- symporter in the DCT.",
      "correct_choice_id": 293808,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85173,
      "choices": [
        {
          "id": 293809,
          "text": "Hydrochlorthiazide"
        },
        {
          "id": 293810,
          "text": "Vasopressin"
        },
        {
          "id": 293811,
          "text": "Chlorpropamide"
        },
        {
          "id": 293812,
          "text": "Carbamazepine"
        }
      ],
      "text": "Which of the following agents is useful for the oral treatment of both pituitary as well as renal diabetes insipidus?",
      "unique_key": "Q4036590",
      "question_audio": null,
      "question_video": null,
      "map_id": 34788814,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Hydrochlorothiazide Hydrochlorothiazide (HCTZ), a thiazide diuretic, is useful in the oral treatment of both central (pituitary) and nephrogenic (renal) diabetes insipidus (DI). While paradoxical, thiazide diuretics work by reducing urine output through a sequence of mechanisms: Increases sodium excretion in the early distal tubule, leading to mild volume depletion. This activates the renin-angiotensin-aldosterone system (RAAS), promoting proximal sodium and water reabsorption. Reduces the volume delivered to the distal nephron, ultimately decreasing urine output. HCTZ is particularly useful in nephrogenic DI, where vasopressin (ADH) resistance is present. However, it also has some efficacy in central DI when desmopressin (DDAVP) is unavailable or unsuitable. Explanation of Incorrect Options: (B) Vasopressin – Incorrect Vasopressin (antidiuretic hormone, ADH) is the treatment of choice for central DI, where the pituitary fails to produce ADH. However, it is not effective in nephrogenic DI, where the kidneys are unresponsive to ADH. It is also not available in oral form, requiring parenteral or intranasal administration. (C) Chlorpropamide – Incorrect Chlorpropamide (a first-generation sulfonylurea) potentiates the effect of ADH on renal tubules, thereby reducing urine output. It is useful only in central DI, where ADH is deficient but still functional. It is not effective in nephrogenic DI, where there is complete ADH resistance. (D) Carbamazepine – Incorrect Carbamazepine stimulates ADH release and enhances its action, making it useful in mild central DI. However, it has no role in nephrogenic DI, where ADH is already present but ineffective.",
      "correct_choice_id": 293809,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85174,
      "choices": [
        {
          "id": 293813,
          "text": "Furosemide"
        },
        {
          "id": 293814,
          "text": "Spironolactone"
        },
        {
          "id": 293815,
          "text": "Acetazolamide"
        },
        {
          "id": 293816,
          "text": "Hydrochlorothiazide"
        }
      ],
      "text": "A 50-year-old has a history of frequent episodes of renal colic with high calcium renal stones. The most useful diuretic in the treatment of recurrent calcium stones is",
      "unique_key": "Q5759180",
      "question_audio": null,
      "question_video": null,
      "map_id": 34801728,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Hydrochlorothiazide The most useful diuretic for treating recurrent calcium renal stones is hydrochlorothiazide (HCTZ), a thiazide diuretic. Thiazides work by inhibiting the Na+/Cl- symporter in the distal convoluted tubule, leading to increased sodium and water excretion. However, they also increase calcium reabsorption, thereby reducing urinary calcium excretion, which helps prevent calcium stone formation. Why Hydrochlorothiazide is Preferred: Hypercalciuria (excess urinary calcium) is a major risk factor for calcium kidney stones. Thiazides reduce urinary calcium excretion, lowering the risk of calcium oxalate and calcium phosphate stone formation. Chronic use of thiazides has been shown to decrease the recurrence of calcium stones. Thus, hydrochlorothiazide is the best choice for patients with recurrent calcium kidney stones. Incorrect Options: (A) Furosemide Loop diuretics (e.g., furosemide) inhibit the Na+-K+-2Cl- symporter in the thick ascending limb, leading to increased calcium excretion in urine. This worsens hypercalciuria and can increase the risk of calcium stone formation, making it a poor choice. (B) Spironolactone Spironolactone is a potassium-sparing diuretic that antagonizes aldosterone at the collecting duct. It does not significantly affect calcium handling and is not effective in preventing kidney stones. (C) Acetazolamide Acetazolamide is a carbonic anhydrase inhibitor that promotes bicarbonate loss and urinary alkalinization. It increases calcium phosphate stone formation by raising urine pH, making it a bad choice for preventing kidney stones.",
      "correct_choice_id": 293816,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70831471698478513/70831471698478513.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70831471698478513/70831471698478513.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85175,
      "choices": [
        {
          "id": 293817,
          "text": "Aldosterone antagonist"
        },
        {
          "id": 293818,
          "text": "Can cause hyperkalemia in predisposed patients"
        },
        {
          "id": 293819,
          "text": "A diuretic"
        },
        {
          "id": 293820,
          "text": "All of these"
        }
      ],
      "text": "Eplerenone is",
      "unique_key": "Q3836188",
      "question_audio": null,
      "question_video": null,
      "map_id": 34873723,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) All of these Eplerenone is a potassium-sparing diuretic and a selective aldosterone antagonist that blocks aldosterone's action at the mineralocorticoid receptors in the distal convoluted tubule and collecting ducts. This leads to increased sodium and water excretion while retaining potassium, making it a diuretic that is particularly useful in conditions like hypertension and heart failure. Additionally, since eplerenone reduces potassium excretion, it can cause hyperkalemia, particularly in patients with renal impairment, diabetes, or those taking other potassium-retaining drugs (ACE inhibitors, ARBs, potassium supplements, etc.). Thus, all the given statements are correct, making option (D) the correct answer. Explanation of Individual Options: (A) Aldosterone Antagonist – Correct Eplerenone competitively inhibits aldosterone at the mineralocorticoid receptor, reducing sodium and water retention while conserving potassium. It is used in hypertension, heart failure (post-MI), and primary hyperaldosteronism. (B) Can Cause Hyperkalemia in Predisposed Patients – Correct By blocking aldosterone, eplerenone reduces potassium excretion, leading to hyperkalemia, especially in: Patients with renal impairment (reduced potassium clearance). Patients on ACE inhibitors/ARBs (which also raise potassium levels). Diabetics, who have altered potassium handling. (C) A Diuretic – Correct Eplerenone acts as a potassium-sparing diuretic, though its diuretic effect is mild compared to loop and thiazide diuretics. It does not cause significant natriuresis, but it is effective in conditions like heart failure and resistant hypertension.",
      "correct_choice_id": 293820,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2579491698478534/2579491698478534.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/2579491698478534/2579491698478534.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85176,
      "choices": [
        {
          "id": 293821,
          "text": "Hyperuricemia"
        },
        {
          "id": 293822,
          "text": "Hyponatremia"
        },
        {
          "id": 293823,
          "text": "Hypokalemia"
        },
        {
          "id": 293824,
          "text": "Hypercalciuria"
        }
      ],
      "text": "Which of the following is NOT associated with thiazide diuretics?",
      "unique_key": "Q8898544",
      "question_audio": null,
      "question_video": null,
      "map_id": 34241689,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Hypercalciuria Thiazide diuretics reduce urinary calcium excretion, leading to hypocalciuria (not hypercalciuria). They achieve this by increasing calcium reabsorption in the distal convoluted tubule (DCT) of the nephron. This effect is useful in preventing calcium-containing kidney stones and is also beneficial for patients with osteoporosis, as it helps increase bone mineral density. Since thiazides decrease urinary calcium loss, hypercalciuria is NOT associated with thiazide diuretics, making option (D) the correct answer. Explanation of Incorrect Options: (A) Hyperuricemia – Incorrect Thiazide diuretics decrease uric acid excretion by promoting its reabsorption in the proximal tubule. This can lead to hyperuricemia, which may predispose individuals to gout. (B) Hyponatremia – Incorrect Thiazides promote sodium excretion by inhibiting the Na?/Cl? symporter in the DCT. This leads to increased sodium loss, resulting in hyponatremia, which is a well-known adverse effect of these diuretics. (C) Hypokalemia – Incorrect Thiazides cause increased sodium delivery to the collecting ducts, where sodium exchange for potassium occurs, leading to potassium loss in urine. This results in hypokalemia, which can lead to muscle weakness, arrhythmias, and metabolic alkalosis.",
      "correct_choice_id": 293824,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25067861698478563/25067861698478563.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/25067861698478563/25067861698478563.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85177,
      "choices": [
        {
          "id": 293825,
          "text": "It decreases calcium loss in the urine"
        },
        {
          "id": 293826,
          "text": "It is the drug of choice for the treatment of lithium induced diabetes insipidus"
        },
        {
          "id": 293827,
          "text": "It antagonises the action of aldosterone"
        },
        {
          "id": 293828,
          "text": "It is more potent than triamterene"
        }
      ],
      "text": "All of the following statements about amiloride are true EXCEPT",
      "unique_key": "Q7046145",
      "question_audio": null,
      "question_video": null,
      "map_id": 34882658,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) It antagonizes the action of aldosterone Amiloride does not antagonize aldosterone directly; instead, it works as a direct inhibitor of epithelial sodium channels (ENaC) in the collecting ducts of the nephron. Unlike spironolactone and eplerenone, which block aldosterone receptors, amiloride prevents sodium reabsorption independently of aldosterone levels. This makes option (C) incorrect because amiloride’s mechanism does not involve direct aldosterone antagonism. Explanation of Incorrect Options: (A) It decreases calcium loss in the urine – Correct Amiloride reduces calcium excretion in the urine by promoting calcium reabsorption in the nephron. This effect is beneficial in conditions like osteoporosis and calcium nephrolithiasis (kidney stones). (B) It is the drug of choice for the treatment of lithium-induced diabetes insipidus – Correct Amiloride is considered the preferred treatment for lithium-induced nephrogenic diabetes insipidus. Lithium enters renal tubular cells via ENaC channels in the collecting ducts, leading to nephrogenic diabetes insipidus. Amiloride blocks these channels, reducing lithium entry and preventing its toxic effects on the kidney. (D) It is more potent than triamterene – Correct Amiloride is generally more potent and longer-acting than triamterene as an ENaC inhibitor. It has a greater effect on sodium retention and potassium-sparing activity, making it clinically more effective.",
      "correct_choice_id": 293827,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44003751698478588/44003751698478588.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/44003751698478588/44003751698478588.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85178,
      "choices": [
        {
          "id": 293829,
          "text": "It acts from the luminal membrane side of the distal tubular cells"
        },
        {
          "id": 293830,
          "text": "Its diuretic action is more in the presence of conditions with elevated aldosterone levels"
        },
        {
          "id": 293831,
          "text": "It has greater natriuretic action"
        },
        {
          "id": 293832,
          "text": "It can cause hypokalemia on long term use"
        }
      ],
      "text": "Amiloride differs from spironolactone in that.",
      "unique_key": "Q3448451",
      "question_audio": null,
      "question_video": null,
      "map_id": 34194438,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) It acts from the luminal membrane side of the distal tubular cells. Amiloride is a potassium-sparing diuretic that works by directly inhibiting the epithelial sodium channels (ENaC) present on the luminal side of the distal convoluted tubule and collecting ducts. This action reduces sodium reabsorption, leading to natriuresis and water excretion, while simultaneously decreasing potassium excretion, thereby preventing hypokalemia. Since amiloride directly blocks sodium channels from the luminal membrane side, it does not rely on aldosterone levels to exert its effect. This differentiates it from spironolactone, which acts as an aldosterone receptor antagonist at the basolateral side of the tubular cells. Explanation of Incorrect Options: (B) Its diuretic action is more in the presence of conditions with elevated aldosterone levels – Incorrect This statement is true for spironolactone, but not for amiloride. Spironolactone works by antagonizing aldosterone receptors, meaning its effect is more pronounced in conditions with high aldosterone levels such as primary hyperaldosteronism or heart failure. Amiloride, on the other hand, works independently of aldosterone because it directly inhibits sodium channels, making it effective even in normal or low aldosterone states. (C) It has greater natriuretic action – Incorrect Amiloride has only a mild diuretic effect since it blocks sodium reabsorption in the distal nephron, where only a small percentage of sodium is reabsorbed. Loop diuretics (e.g., furosemide) and thiazide diuretics have a much stronger natriuretic effect because they act earlier in the nephron, where more sodium is reabsorbed. Spironolactone and amiloride have similar weak natriuretic actions, and amiloride does not have a greater natriuretic effect than spironolactone. (D) It can cause hypokalemia on long-term use – Incorrect Amiloride is a potassium-sparing diuretic, meaning it prevents potassium loss rather than causing hypokalemia. By blocking sodium entry through ENaC, it reduces potassium secretion into the urine. Instead of hypokalemia, prolonged use of amiloride, especially in patients with renal impairment or those taking potassium supplements, can lead to hyperkalemia, which can be a serious side effect.",
      "correct_choice_id": 293829,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38840541698478603/38840541698478603.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/38840541698478603/38840541698478603.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85179,
      "choices": [
        {
          "id": 293833,
          "text": "Electrogenic K+ channels"
        },
        {
          "id": 293834,
          "text": "H+K+ ATPase"
        },
        {
          "id": 293835,
          "text": "Non Electrogenic Na+Cl- symporter"
        },
        {
          "id": 293836,
          "text": "Electrogenic Na+ channels"
        }
      ],
      "text": "Amiloride can cause hyperkalemia due to its action on",
      "unique_key": "Q4006795",
      "question_audio": null,
      "question_video": null,
      "map_id": 34707114,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Electrogenic Na+ channels. Amiloride is a potassium-sparing diuretic that acts by directly inhibiting epithelial sodium channels (ENaC) in the luminal membrane of the distal convoluted tubule and collecting duct. These channels are electrogenic, meaning they generate an electrical gradient by allowing sodium (Na+) to enter the tubular cells from the urine. Normally, this sodium reabsorption creates a negative lumen potential, which drives potassium (K+) secretion into the urine through potassium channels. By blocking electrogenic Na+ channels, amiloride reduces sodium reabsorption, which in turn decreases the driving force for potassium secretion, leading to potassium retention and hyperkalemia. Incorrect Options: (A) Electrogenic K+ channels – Incorrect While potassium channels in the distal nephron contribute to potassium excretion, amiloride does not directly block them. Instead, it indirectly reduces potassium secretion by blocking sodium entry through ENaC, thereby reducing the electrochemical gradient that normally promotes potassium efflux into the urine. (B) H+/K+ ATPase – Incorrect The H+/K+ ATPase is primarily found in the gastric parietal cells (where it helps with acid secretion) and in the renal collecting duct intercalated cells, where it plays a role in acid-base balance rather than sodium and potassium handling. Amiloride does not act on this pump. (C) Non-electrogenic Na+/Cl- symporter – Incorrect The Na+/Cl- symporter (NCC) is found in the early distal convoluted tubule and is responsible for sodium and chloride reabsorption. It is the target of thiazide diuretics, not amiloride. Amiloride acts later in the nephron, specifically in the collecting duct, where it inhibits electrogenic sodium channels (ENaC).",
      "correct_choice_id": 293836,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42006121698478623/42006121698478623.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42006121698478623/42006121698478623.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85180,
      "choices": [
        {
          "id": 293837,
          "text": "Increasing the availability of Na+ in the distal tubular fluid to exchange with interstitial K+"
        },
        {
          "id": 293838,
          "text": "Inhibiting Na-K-2C1 cotransport in the ascending limb of loop of Henle"
        },
        {
          "id": 293839,
          "text": "Inhibiting proximal tubular K reabsorption"
        },
        {
          "id": 293840,
          "text": "Potentiating the action of aldosterone"
        }
      ],
      "text": "Both loop diuretics and thiazides can cause hypokalemia by",
      "unique_key": "Q7609473",
      "question_audio": null,
      "question_video": null,
      "map_id": 34680114,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Increasing the availability of Na+ in the distal tubular fluid to exchange with interstitial K+. Both loop diuretics (e.g., furosemide) and thiazide diuretics act upstream in the nephron, leading to increased sodium delivery to the distal convoluted tubule and collecting duct. In these segments, sodium (Na+) is reabsorbed through epithelial sodium channels (ENaC), which generates a negative lumen potential. This negative charge drives the secretion of potassium (K+) into the tubular lumen via potassium channels, leading to increased potassium excretion and hypokalemia. Since both loop and thiazide diuretics increase sodium delivery to this site, they indirectly enhance potassium loss through this mechanism. Incorrect Options: (B) Inhibiting Na+-K+-2Cl- cotransport in the ascending limb of the loop of Henle – Incorrect This mechanism is specific to loop diuretics, such as furosemide, which block the Na+-K+-2Cl- (NKCC2) cotransporter in the thick ascending limb of the loop of Henle. While this leads to natriuresis, it does not directly explain hypokalemia, as potassium is reabsorbed at this site. The primary cause of potassium loss is the increased sodium delivery to the distal nephron, which enhances potassium secretion. Moreover, thiazides do not act at this site, making this answer incorrect for thiazides. (C) Inhibiting proximal tubular K+ reabsorption – Incorrect Neither loop nor thiazide diuretics act directly on potassium handling in the proximal tubule. Most potassium reabsorption occurs passively in the proximal tubule and is not a major site for potassium regulation. The primary cause of hypokalemia with these diuretics occurs distally, where increased sodium availability enhances potassium secretion. (D) Potentiating the action of aldosterone – Incorrect Aldosterone promotes sodium retention and potassium excretion by increasing the activity of ENaC in the collecting duct. However, loop and thiazide diuretics do not directly enhance aldosterone action. Instead, the increased sodium delivery to the distal tubule and collecting duct indirectly stimulates aldosterone release as a secondary compensatory mechanism, which can contribute to potassium loss. However, this effect is not the primary cause of diuretic-induced hypokalemia, making this option incorrect.",
      "correct_choice_id": 293837,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55924361698478644/55924361698478644.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55924361698478644/55924361698478644.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85181,
      "choices": [
        {
          "id": 293841,
          "text": "Furosemide"
        },
        {
          "id": 293842,
          "text": "Ethacrynic Acid"
        },
        {
          "id": 293843,
          "text": "Torsemide"
        },
        {
          "id": 293844,
          "text": "Bumetanide"
        }
      ],
      "text": "Most potent loop diuretic is",
      "unique_key": "Q7134111",
      "question_audio": null,
      "question_video": null,
      "map_id": 34714851,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Bumetanide. Among loop diuretics, bumetanide is the most potent because it has the highest bioavailability and potency per milligram. Like other loop diuretics, bumetanide acts on the Na?-K?-2Cl? (NKCC2) cotransporter in the thick ascending limb of the loop of Henle, inhibiting sodium, potassium, and chloride reabsorption. This leads to significant natriuresis and diuresis. Compared to furosemide, bumetanide is 40 times more potent, meaning a much lower dose is needed to achieve the same diuretic effect. This makes it particularly useful in patients with diuretic resistance or those requiring stronger diuresis with smaller doses. Explanation of Incorrect Options: (A) Furosemide – Incorrect Furosemide is the most commonly used loop diuretic, but it is less potent than bumetanide. It has variable bioavailability (10-100%), meaning its effect can be inconsistent. A higher dose is required compared to bumetanide to achieve the same level of diuresis. (B) Ethacrynic Acid – Incorrect Ethacrynic acid is unique because it is the only loop diuretic that does not contain a sulfonamide group, making it useful for patients with sulfa allergies. However, it is less potent than bumetanide and has a higher risk of ototoxicity, limiting its widespread use. (C) Torsemide – Incorrect Torsemide has a longer half-life than furosemide, leading to more sustained diuresis. However, it is less potent than bumetanide. It is often preferred in chronic heart failure due to its once-daily dosing and better bioavailability, but it does not surpass bumetanide in potency.",
      "correct_choice_id": 293844,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42707791698478656/42707791698478656.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42707791698478656/42707791698478656.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85182,
      "choices": [
        {
          "id": 293845,
          "text": "Causing venodilation"
        },
        {
          "id": 293846,
          "text": "Causing rapid diuresis and reducing circulating blood volume"
        },
        {
          "id": 293847,
          "text": "Producing bronchodilation"
        },
        {
          "id": 293848,
          "text": "Stimulating left ventricular contractility"
        }
      ],
      "text": "Intravenous furosemide is used for rapid control of symptoms in acute left ventricular failure. It provides quick relief of dyspnoea by",
      "unique_key": "Q1886589",
      "question_audio": null,
      "question_video": null,
      "map_id": 34891973,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Causing venodilation. Intravenous (IV) furosemide provides rapid relief of dyspnea in acute left ventricular failure (LVF) primarily through venodilation, which occurs before its diuretic effect sets in. Venodilation reduces preload (venous return to the heart) by pooling blood in the peripheral veins, thereby decreasing pulmonary congestion and reducing pulmonary capillary hydrostatic pressure. This leads to immediate symptomatic relief of dyspnea even before significant diuresis occurs. The venodilatory effect is mediated by prostaglandin release and occurs within minutes of IV administration. Explanation of Incorrect Options: (B) Causing rapid diuresis and reducing circulating blood volume – Incorrect While furosemide is a potent diuretic that reduces blood volume and lowers preload and afterload, its diuretic action takes time (about 30–60 minutes after IV administration). The initial relief of dyspnea in acute LVF occurs within minutes, which is too quick to be explained by diuresis. Thus, venodilation is the primary mechanism for immediate symptom relief, making option A more correct than B. (C) Producing bronchodilation – Incorrect Furosemide does not have a direct bronchodilatory effect. While some studies suggest a possible role in reducing bronchial hyperreactivity, this is not its primary mechanism in acute LVF. Dyspnea in LVF is caused by pulmonary congestion, not bronchospasm, making this option incorrect. (D) Stimulating left ventricular contractility – Incorrect Furosemide does not enhance myocardial contractility. Instead, it primarily reduces preload and afterload, indirectly improving cardiac function by decreasing the workload on the failing left ventricle. Drugs like dobutamine or milrinone are used to enhance contractility in heart failure, not furosemide.",
      "correct_choice_id": 293845,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85183,
      "choices": [
        {
          "id": 293849,
          "text": "Furosemide"
        },
        {
          "id": 293850,
          "text": "Acetazolamide"
        },
        {
          "id": 293851,
          "text": "Spironolactone"
        },
        {
          "id": 293852,
          "text": "Chlorthalidone"
        }
      ],
      "text": "Which of the following diuretic acts by inhibiting Na+-Cl symport",
      "unique_key": "Q7684848",
      "question_audio": null,
      "question_video": null,
      "map_id": 34315359,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Chlorthalidone. Chlorthalidone is a thiazide-like diuretic that exerts its action by inhibiting the Na+-Cl- symporter in the distal convoluted tubule (DCT) of the nephron. By blocking this transporter, it reduces sodium and chloride reabsorption, leading to increased excretion of sodium, chloride, and water. This results in a diuretic effect and is particularly useful in treating hypertension, heart failure, and edema. Thiazide diuretics also cause potassium loss, leading to potential hypokalemia as a side effect. Incorrect Options: (A) Furosemide Furosemide is a loop diuretic that inhibits the Na+-K+-2Cl- cotransporter in the thick ascending limb of the loop of Henle, not the Na+-Cl- symporter in the DCT. This results in more potent diuresis compared to thiazides but does not match the mechanism of action described in the question. (B) Acetazolamide Acetazolamide is a carbonic anhydrase inhibitor that works in the proximal tubule by inhibiting bicarbonate (HCO3-) reabsorption. It causes a mild diuresis and is mainly used in conditions like glaucoma, altitude sickness, and metabolic alkalosis, rather than as a primary diuretic. It does not act on the Na+-Cl- symporter. (C) Spironolactone Spironolactone is a potassium-sparing diuretic that works as an aldosterone antagonist in the collecting duct. By blocking aldosterone receptors, it reduces sodium reabsorption and potassium excretion. It does not directly inhibit sodium transporters like the Na+-Cl- symporter, making it the wrong choice",
      "correct_choice_id": 293852,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50126081698478899/50126081698478899.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/50126081698478899/50126081698478899.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85184,
      "choices": [
        {
          "id": 293853,
          "text": "Restricting dietary Na+ intake"
        },
        {
          "id": 293854,
          "text": "Moe frequent administration of the loop diuretic"
        },
        {
          "id": 293855,
          "text": "Both A and B"
        },
        {
          "id": 293856,
          "text": "Adding Potassium sparing diuretic"
        }
      ],
      "text": "Loop diuretics causes ‘postdiuretic Na+ retention due to their short half-life, this can be overcome by",
      "unique_key": "Q6480984",
      "question_audio": null,
      "question_video": null,
      "map_id": 34400375,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Both A and B. Loop diuretics, such as furosemide, bumetanide, and torsemide, have a short half-life, which leads to postdiuretic sodium (Na?) retention. This occurs because once the drug effect wears off, the kidney compensates by increasing sodium reabsorption, reducing the overall diuretic efficacy. To counteract this effect: Restricting dietary Na? intake (Option A) – By limiting sodium intake, less sodium is available for reabsorption, reducing the impact of postdiuretic sodium retention. More frequent administration of the loop diuretic (Option B) – Dividing the total daily dose into multiple smaller doses ensures a more sustained diuretic effect, preventing the kidney from compensating with sodium retention once the drug effect diminishes. Thus, using both strategies together (Option C) is the most effective approach to mitigate postdiuretic sodium retention. Explanation of Incorrect Options: (D) Adding a potassium-sparing diuretic – Incorrect While potassium-sparing diuretics (e.g., spironolactone, amiloride) help counteract hypokalemia caused by loop diuretics, they do not specifically prevent postdiuretic sodium retention. They act at the collecting duct rather than directly addressing the loop of Henle's compensatory mechanisms. Therefore, this option alone is not the best solution.",
      "correct_choice_id": 293855,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85185,
      "choices": [
        {
          "id": 293857,
          "text": "Acetazolamide"
        },
        {
          "id": 293858,
          "text": "Triamterene"
        },
        {
          "id": 293859,
          "text": "Spironolactone"
        },
        {
          "id": 293860,
          "text": "None of the above"
        }
      ],
      "text": "The following drugs are used in treatment of Liddle syndrome except",
      "unique_key": "Q8891054",
      "question_audio": null,
      "question_video": null,
      "map_id": 34153779,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Spironolactone. Liddle syndrome is a rare genetic disorder characterized by increased activity of the epithelial sodium channel (ENaC) in the distal nephron, leading to excessive sodium reabsorption, hypokalemia, metabolic alkalosis, and hypertension. The treatment focuses on blocking ENaC directly, rather than targeting aldosterone. Spironolactone is incorrect because it is an aldosterone antagonist, and Liddle syndrome is aldosterone-independent, meaning spironolactone is ineffective in this condition. Explanation for incorrect options: Option A: Acetazolamide – This is a carbonic anhydrase inhibitor that promotes bicarbonate excretion and can help in mild diuresis. While not a primary treatment, it can be useful in managing metabolic alkalosis, making it a reasonable option in some cases. Option B: Triamterene – This drug is a potassium-sparing diuretic that directly inhibits ENaC, which is the underlying problem in Liddle syndrome. By blocking sodium reabsorption, it helps correct hypertension and hypokalemia, making it an effective treatment. Option D: None of the above – Since spironolactone is not effective, this option is incorrect.",
      "correct_choice_id": 293859,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85186,
      "choices": [
        {
          "id": 293861,
          "text": "Older patients"
        },
        {
          "id": 293862,
          "text": "Pregnancy induced hypertension"
        },
        {
          "id": 293863,
          "text": "Isolated systolic hypertension"
        },
        {
          "id": 293864,
          "text": "Obese with volume overload"
        }
      ],
      "text": "Thiazide diuretics as anti-hypertensive are to avoided in",
      "unique_key": "Q9495681",
      "question_audio": null,
      "question_video": null,
      "map_id": 34832269,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Pregnancy-induced hypertension. Thiazide diuretics are generally avoided in pregnancy, particularly in cases of pregnancy-induced hypertension (PIH) or pre-eclampsia, because they can potentially harm both the mother and fetus. Thiazide diuretics reduce plasma volume and can cause electrolyte imbalances, which may exacerbate complications like hypokalemia and dehydration. Additionally, there is some evidence suggesting that thiazides may reduce uteroplacental blood flow, which could be detrimental during pregnancy, especially in cases of PIH where placental perfusion is already compromised. Therefore, thiazide diuretics are generally avoided in pregnancy, and other antihypertensive agents like methyldopa, labetalol, or nifedipine are preferred. Explanation for incorrect responses: Option A: Older patients – Thiazide diuretics can be used in older patients with hypertension. In fact, thiazides are often first-line agents in managing hypertension in elderly patients because they are effective in lowering blood pressure and are generally well tolerated in this age group. However, caution should be taken regarding possible electrolyte imbalances, especially hypokalemia, which can be more pronounced in the elderly. But overall, older patients are not contraindicated for thiazide use. Option C: Isolated systolic hypertension – Thiazide diuretics are commonly used in the treatment of isolated systolic hypertension, which is especially prevalent in older adults. Thiazides can reduce systolic blood pressure effectively, which is beneficial in this condition. Therefore, thiazide diuretics are actually recommended in managing isolated systolic hypertension. Option D: Obese with volume overload – Thiazide diuretics can be useful in obese patients with volume overload (such as in cases of heart failure or hypertension). They help to reduce fluid retention, making them effective in managing hypertension in obese patients. However, they should be used cautiously in patients with renal dysfunction or those who are at risk of electrolyte imbalances.",
      "correct_choice_id": 293862,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7624381698479619/7624381698479619.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/7624381698479619/7624381698479619.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85187,
      "choices": [
        {
          "id": 293865,
          "text": "Acetazolamide"
        },
        {
          "id": 293866,
          "text": "Amiloride"
        },
        {
          "id": 293867,
          "text": "Chlorothiazide"
        },
        {
          "id": 293868,
          "text": "Spironolactone"
        }
      ],
      "text": "A patient taking a diuretic for several months presents with significantly elevated serum glucose levels. You suspect it is diuretic induced. Which of the following is the most likely cause?",
      "unique_key": "Q8015425",
      "question_audio": null,
      "question_video": null,
      "map_id": 34323784,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Chlorothiazide. Thiazide diuretics, such as chlorothiazide, are known to potentially increase serum glucose levels. Thiazides can induce insulin resistance, which decreases the body’s ability to use glucose effectively, thereby leading to hyperglycemia. In addition, they can reduce the secretion of insulin from the pancreas, further contributing to elevated blood sugar levels. This is a well-known side effect of thiazide diuretics, particularly with long-term use. Explanation of Incorrect Options: (A) Acetazolamide – Incorrect. Acetazolamide is a carbonic anhydrase inhibitor that is used primarily as a diuretic for conditions such as glaucoma and altitude sickness, but it is not commonly associated with elevated glucose levels. It works differently from thiazide diuretics, and its primary side effects involve metabolic acidosis and electrolyte imbalances, rather than hyperglycemia. (B) Amiloride – Incorrect. Amiloride is a potassium-sparing diuretic that works by inhibiting sodium reabsorption in the distal nephron. While it can affect potassium and sodium balance, amiloride does not typically cause a significant rise in glucose levels. It has a relatively favorable side effect profile, and hyperglycemia is not a common issue associated with this drug. (D) Spironolactone – Incorrect. Spironolactone is an aldosterone antagonist used primarily for conditions such as heart failure and hyperaldosteronism. It does not typically lead to significant elevations in glucose levels. In fact, spironolactone’s side effects are more related to hyperkalemia and gynecomastia, rather than hyperglycemia. Therefore, spironolactone is not a likely cause of elevated serum glucose levels.",
      "correct_choice_id": 293867,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30148371700305021/30148371700305021.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/30148371700305021/30148371700305021.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85188,
      "choices": [
        {
          "id": 293869,
          "text": "Fall of blood pressure sufficient to cause syncope"
        },
        {
          "id": 293870,
          "text": "Onset of acute heart failure from depression of ventricular contractility"
        },
        {
          "id": 293871,
          "text": "Paradoxical hypertensive crisis"
        },
        {
          "id": 293872,
          "text": "Sudden prolongation of the P-R interval and increasing degrees of the heart block"
        }
      ],
      "text": "A patient of essential HTN is treated with usually effective doses of an ACE Inhibitor. After a suitable period of time, BP has not been lowered satisfactorily. A thiazide is added to the regimen . Which of the following is most likely and earliest untoward outcome of this drug add on, for which you should monitor closely?",
      "unique_key": "Q9167694",
      "question_audio": null,
      "question_video": null,
      "map_id": 34758914,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Fall of blood pressure sufficient to cause syncope. When a thiazide diuretic is added to an ACE inhibitor in the treatment of essential hypertension, the most likely and earliest untoward outcome is an excessive drop in blood pressure, which could lead to syncope. Thiazides are effective in lowering blood pressure by reducing blood volume through fluid excretion, and when combined with an ACE inhibitor (which also lowers blood pressure by inhibiting the renin-angiotensin-aldosterone system), the blood pressure-lowering effect can be additive. This combination can lead to an excessive fall in blood pressure, especially in the initial stages of treatment, putting the patient at risk for dizziness, lightheadedness, and syncope. This is particularly concerning when standing up quickly (orthostatic hypotension), so close monitoring of blood pressure is required when initiating or adjusting therapy. Explanation of Incorrect Options: (B) Onset of acute heart failure from depression of ventricular contractility – Incorrect. The combination of an ACE inhibitor and thiazide is not typically associated with the depression of ventricular contractility. ACE inhibitors may have a mild effect on improving heart function in patients with heart failure, and thiazides generally do not directly affect contractility. While thiazides can exacerbate heart failure if fluid overload is not managed, they are not commonly linked to causing acute heart failure through a reduction in contractility. The primary concern with thiazide diuretics and ACE inhibitors is their blood pressure-lowering effects rather than a direct effect on myocardial contractility. (C) Paradoxical hypertensive crisis – Incorrect. A paradoxical hypertensive crisis is extremely unlikely with the use of ACE inhibitors and thiazides in treating essential hypertension. Both drugs are used to reduce, not increase, blood pressure. A hypertensive crisis typically arises from abrupt withdrawal of antihypertensive medications, but the combination of ACE inhibitors and thiazides generally does not cause a paradoxical increase in blood pressure. If anything, they would work together to lower it, not raise it. (D) Sudden prolongation of the P-R interval and increasing degrees of heart block – Incorrect. While certain medications (e.g., beta-blockers, calcium channel blockers) can cause prolongation of the P-R interval and lead to heart block, ACE inhibitors and thiazides are not typically associated with such effects. ACE inhibitors may cause mild electrolyte imbalances (e.g., hyperkalemia), but they do not directly affect the conduction system of the heart. Similarly, thiazides primarily work on the kidneys and are unlikely to cause significant changes in the P-R interval. The combination of these drugs does not directly contribute to heart block, and any impact on heart rhythm would likely be due to electrolyte disturbances (such as hypokalemia), rather than a direct effect on conduction.",
      "correct_choice_id": 293869,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39355301700305067/39355301700305067.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/39355301700305067/39355301700305067.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85189,
      "choices": [
        {
          "id": 293873,
          "text": "Bumetanide"
        },
        {
          "id": 293874,
          "text": "Torsemide"
        },
        {
          "id": 293875,
          "text": "Furosemide"
        },
        {
          "id": 293876,
          "text": "Hydrochlorothiazide"
        }
      ],
      "text": "A 70-year-old man is admitted with a history of heart failure and an acute left ventricular myocardial infarction. He has severe pulmonary edema. Which of the following drugs is LEAST likely to prove useful in the treatment of acute pulmonary edema?",
      "unique_key": "Q9740235",
      "question_audio": null,
      "question_video": null,
      "map_id": 34430313,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Hydrochlorothiazide. Hydrochlorothiazide is the least useful drug in the treatment of acute pulmonary edema, particularly in the context of a severe acute left ventricular myocardial infarction. Thiazide diuretics like hydrochlorothiazide are generally less effective in managing acute pulmonary edema compared to loop diuretics. While thiazides are useful for managing chronic hypertension and mild edema, their efficacy is significantly reduced in the case of severe pulmonary edema, where rapid and potent diuresis is required. Loop diuretics like bumetanide, torsemide, and furosemide work more effectively by promoting substantial fluid loss, which is crucial in managing acute fluid overload in pulmonary edema. Therefore, hydrochlorothiazide is less likely to provide the necessary rapid diuresis in this emergency setting. Explanation of Incorrect Options: (A) Bumetanide – Incorrect. Bumetanide is a loop diuretic that is highly effective in treating conditions like pulmonary edema. It acts quickly to promote significant fluid loss by inhibiting sodium and chloride reabsorption in the loop of Henle, leading to a powerful diuretic effect. In the context of acute left ventricular myocardial infarction with severe pulmonary edema, bumetanide is an appropriate choice due to its rapid onset of action and efficacy in relieving fluid overload in the lungs. (B) Torsemide – Incorrect. Torsemide is another loop diuretic, similar to bumetanide, and is equally effective in treating acute pulmonary edema. It works by inhibiting sodium and chloride reabsorption in the loop of Henle, thus promoting rapid diuresis. It has a similar clinical use and efficacy profile as bumetanide and furosemide and is appropriate for managing fluid overload in cases of acute heart failure and pulmonary edema. (C) Furosemide – Incorrect. Furosemide is a well-known loop diuretic and is often the first-line treatment for acute pulmonary edema. It is highly effective in rapidly reducing fluid accumulation in the lungs by promoting renal excretion of sodium, chloride, and water. Furosemide has a proven track record of improving symptoms of pulmonary edema in patients with heart failure or following myocardial infarction, making it one of the most commonly used diuretics in this clinical scenario.",
      "correct_choice_id": 293876,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54329691700305081/54329691700305081.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/54329691700305081/54329691700305081.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85190,
      "choices": [
        {
          "id": 293877,
          "text": "Acetazolamide"
        },
        {
          "id": 293878,
          "text": "Furosemide"
        },
        {
          "id": 293879,
          "text": "Spironolactone"
        },
        {
          "id": 293880,
          "text": "Hydrochlorothiazide"
        }
      ],
      "text": "A 50-year-old man has a history of frequent episodes of renal colic with high-calcium renal stones. The most useful agent in the treatment of recurrent calcium stones is",
      "unique_key": "Q9169964",
      "question_audio": null,
      "question_video": null,
      "map_id": 34141893,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Hydrochlorothiazide. Hydrochlorothiazide is the most useful agent in the treatment of recurrent calcium renal stones, specifically calcium oxalate stones. It works by reducing urinary calcium excretion through its action as a thiazide diuretic. By inhibiting sodium reabsorption in the distal convoluted tubule, hydrochlorothiazide promotes calcium reabsorption in the renal tubules, which decreases urinary calcium levels and helps prevent the formation of calcium stones. This makes it a highly effective treatment for patients with hypercalciuria, a common cause of calcium stone formation. Thus, it is commonly used to prevent the recurrence of calcium-based kidney stones. Explanation of Incorrect Options: (A) Acetazolamide – Incorrect. Acetazolamide is a carbonic anhydrase inhibitor that works by increasing the excretion of bicarbonate, which leads to a mild alkalinization of the urine. While it may have some utility in treating urinary alkalinization in specific types of stones (e.g., uric acid stones), it is not effective in treating calcium-based renal stones. Acetazolamide does not reduce calcium excretion or help prevent the formation of calcium stones, which is why it is not recommended for this particular condition. (B) Furosemide – Incorrect. Furosemide is a loop diuretic that increases urine output by inhibiting sodium and chloride reabsorption in the loop of Henle. However, furosemide is not effective in preventing calcium stone formation. In fact, loop diuretics may increase urinary calcium excretion, which could potentially worsen the risk of calcium stone formation. Therefore, furosemide is not recommended for patients with a history of calcium kidney stones. (C) Spironolactone – Incorrect. Spironolactone is a potassium-sparing diuretic that works by blocking the action of aldosterone, thus reducing sodium reabsorption and promoting potassium retention. Although it can help with conditions such as heart failure or hypertension, it does not affect calcium excretion in the urine. As such, it is not effective in preventing calcium stone formation and is not a suitable treatment for this patient.",
      "correct_choice_id": 293880,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58903341700305094/58903341700305094.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/58903341700305094/58903341700305094.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85191,
      "choices": [
        {
          "id": 293881,
          "text": "Amiloride"
        },
        {
          "id": 293882,
          "text": "Hydrochlorothiazide"
        },
        {
          "id": 293883,
          "text": "Losartan"
        },
        {
          "id": 293884,
          "text": "Spironolactone"
        }
      ],
      "text": "A patient with long-standing diabetic renal disease and hyperkalemia and recent-onset congestive heart failure requires a diuretic. Which of the following agents would be LEAST harmful in a patient with severe hyperkalemia?",
      "unique_key": "Q4749390",
      "question_audio": null,
      "question_video": null,
      "map_id": 34899603,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Hydrochlorothiazide. Hydrochlorothiazide (HCTZ) is the least harmful diuretic in a patient with severe hyperkalemia because it is a thiazide diuretic that primarily promotes potassium excretion rather than retention. Thiazide diuretics act on the distal convoluted tubule of the nephron, inhibiting sodium reabsorption, leading to increased urinary potassium excretion. In patients with hyperkalemia, hydrochlorothiazide helps reduce potassium levels, making it a safer choice compared to other options that may worsen hyperkalemia. Explanation of Incorrect Options: (A) Amiloride – Incorrect. Amiloride is a potassium-sparing diuretic that works by blocking epithelial sodium channels (ENaC) in the distal nephron, leading to potassium retention. In a patient with severe hyperkalemia, amiloride would worsen the condition by further increasing potassium levels. Thus, it is not a suitable diuretic choice for this patient. (C) Losartan – Incorrect. Losartan is an angiotensin II receptor blocker (ARB), which inhibits the renin-angiotensin-aldosterone system (RAAS). RAAS blockade leads to reduced aldosterone levels, resulting in potassium retention. Since the patient already has hyperkalemia, losartan would further increase potassium levels, making it an inappropriate choice. (D) Spironolactone – Incorrect. Spironolactone is a potassium-sparing diuretic and aldosterone antagonist. It works by blocking aldosterone receptors, leading to reduced potassium excretion and increased potassium retention. In a patient with severe hyperkalemia, spironolactone would exacerbate the problem, making it unsafe in this situation.",
      "correct_choice_id": 293882,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23833921700305108/23833921700305108.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23833921700305108/23833921700305108.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85192,
      "choices": [
        {
          "id": 293885,
          "text": "Acetazolamide"
        },
        {
          "id": 293886,
          "text": "Amiloride"
        },
        {
          "id": 293887,
          "text": "Furosemide"
        },
        {
          "id": 293888,
          "text": "Hydrochlorothiazide"
        }
      ],
      "text": "A 70-year-old woman is admitted to the emergency room because of a \"fainting spell\" at home. She appears to have suffered no trauma from her fall, but her blood pressure is 110/60 when lying down and 60/40 when she sits up. Neurologic examination and an ECG are within normal limits when she is lying down. Questioning reveals that she has recently started taking diuretics for a heart condition. Which of the following drugs is the most likely cause of her fainting spell?",
      "unique_key": "Q4161253",
      "question_audio": null,
      "question_video": null,
      "map_id": 34304244,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Furosemide. Furosemide is a loop diuretic that acts on the Na+/K+/2Cl- cotransporter in the thick ascending limb of the loop of Henle, leading to significant diuresis and electrolyte loss. Due to its potent natriuretic and volume-depleting effects, furosemide can cause hypotension and dehydration, which may lead to orthostatic hypotension and syncope (fainting spells), as seen in this patient. The drop in blood pressure upon sitting up suggests volume depletion, a common side effect of loop diuretics, making furosemide the most likely culprit. Explanation of Incorrect Options: (A) Acetazolamide Acetazolamide is a carbonic anhydrase inhibitor that primarily promotes bicarbonate diuresis in the proximal tubule, leading to mild metabolic acidosis. It does not cause significant volume depletion or orthostatic hypotension, making it unlikely to be responsible for the patient’s symptoms. (B) Amiloride Amiloride is a potassium-sparing diuretic that blocks epithelial sodium channels (ENaC) in the collecting duct. It has mild diuretic effects and is not typically associated with significant volume depletion or orthostatic hypotension, making it an unlikely cause of the patient’s fainting. (D) Hydrochlorothiazide Hydrochlorothiazide (HCTZ) is a thiazide diuretic that acts on the distal convoluted tubule, causing moderate natriuresis. While it can cause hypotension, it is less potent than furosemide in causing volume depletion. Additionally, thiazides cause more gradual sodium loss rather than the rapid volume depletion seen with loop diuretics like furosemide, making it a less likely cause of the patient’s acute symptoms.",
      "correct_choice_id": 293887,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36013761700305122/36013761700305122.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/36013761700305122/36013761700305122.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85193,
      "choices": [
        {
          "id": 293889,
          "text": "Acetazolamide"
        },
        {
          "id": 293890,
          "text": "Amiloride"
        },
        {
          "id": 293891,
          "text": "Furosemide"
        },
        {
          "id": 293892,
          "text": "Hydrochlorothiazide"
        }
      ],
      "text": "A 55-year-old patient with severe post-hepatitis cirrhosis is started on a diuretic for another condition. Two days later he is found in a coma. The drug most likely to cause coma in a patient with cirrhosis is",
      "unique_key": "Q3773724",
      "question_audio": null,
      "question_video": null,
      "map_id": 34865035,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Acetazolamide. Acetazolamide is a carbonic anhydrase inhibitor that acts in the proximal convoluted tubule to increase bicarbonate excretion, leading to metabolic acidosis. In patients with hepatic cirrhosis, metabolic acidosis can worsen hepatic encephalopathy, as the resulting acidemia promotes ammonia entry into the brain, leading to neurological deterioration and coma. Additionally, acetazolamide can cause electrolyte imbalances (hypokalemia and hyponatremia), which further contribute to worsening encephalopathy in cirrhotic patients. Explanation of Incorrect Options: (B) Amiloride Amiloride is a potassium-sparing diuretic that blocks epithelial sodium channels (ENaC) in the collecting ducts. It has a relatively mild diuretic effect and does not cause significant metabolic disturbances. Unlike acetazolamide, it does not promote metabolic acidosis, making it less likely to induce hepatic encephalopathy. (C) Furosemide Furosemide is a loop diuretic that causes potent natriuresis by inhibiting the Na+/K+/2Cl- transporter in the thick ascending limb of the loop of Henle. While furosemide can cause electrolyte imbalances, volume depletion, and worsen hepatorenal syndrome, it does not directly precipitate metabolic acidosis, making it less likely to cause coma in a cirrhotic patient. (D) Hydrochlorothiazide Hydrochlorothiazide (HCTZ) is a thiazide diuretic that works on the distal convoluted tubule, leading to moderate sodium excretion. It does not significantly alter acid-base balance, and while it can cause hypokalemia and hyponatremia, it is less likely to trigger hepatic coma than acetazolamide.",
      "correct_choice_id": 293889,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70742811700305135/70742811700305135.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70742811700305135/70742811700305135.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85194,
      "choices": [
        {
          "id": 293893,
          "text": "Acetazolamide"
        },
        {
          "id": 293894,
          "text": "Furosemide"
        },
        {
          "id": 293895,
          "text": "Hydrochlorothiazide"
        },
        {
          "id": 293896,
          "text": "Mannitol"
        }
      ],
      "text": "A 47-year-old woman with Type-2 diabetes presents to the nephrology clinic for follow-up. She has been doing well other than an increase in her blood sugars lately. She was started on a new medication recently, but she cannot remember the name. All she knows was it affected her kidneys. What is the most likely medication that she started taking?",
      "unique_key": "Q4646042",
      "question_audio": null,
      "question_video": null,
      "map_id": 34747706,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Hydrochlorothiazide. Hydrochlorothiazide (HCTZ) is a thiazide diuretic that works by inhibiting the Na+/Cl+ cotransporter in the distal convoluted tubule of the kidney. It is commonly used for hypertension and mild fluid retention, especially in patients with conditions like diabetes and chronic kidney disease. Why is Hydrochlorothiazide the Most Likely Medication? Thiazide diuretics can affect glucose metabolism, leading to hyperglycemia, which explains why this patient has noticed an increase in blood sugars. The mechanism of hyperglycemia is related to reduced insulin secretion and increased insulin resistance caused by thiazides. Thiazides also affect kidney function by reducing sodium reabsorption, potentially impacting electrolyte balance and causing mild volume depletion. Patients with Type 2 diabetes often have hypertension, making thiazides a common choice for their treatment. Explanation of Incorrect Options: (A) Acetazolamide: A carbonic anhydrase inhibitor that works in the proximal tubule, reducing bicarbonate reabsorption. Used for glaucoma, metabolic alkalosis, and altitude sickness, but not a common antihypertensive or diabetes-related medication. Unlike thiazides, it does not typically cause hyperglycemia. (B) Furosemide: A loop diuretic that inhibits the Na+/K+/2Cl- cotransporter in the loop of Henle, leading to significant diuresis. Used for heart failure, edema, and hypertension, but less commonly prescribed for routine blood pressure control in diabetics unless they have severe fluid overload. Does not significantly affect blood glucose levels, unlike thiazides. (D) Mannitol: An osmotic diuretic that works by drawing water into the renal tubules, increasing urine output. Used for cerebral edema, increased intracranial pressure, and acute kidney injury, but not for hypertension or diabetes management. Does not typically cause hyperglycemia.",
      "correct_choice_id": 293895,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70562891700305590/70562891700305590.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/70562891700305590/70562891700305590.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85195,
      "choices": [
        {
          "id": 293897,
          "text": "Ascending limb of loop of Henle"
        },
        {
          "id": 293898,
          "text": "Collecting tubule"
        },
        {
          "id": 293899,
          "text": "Descending limb of loop of Henle"
        },
        {
          "id": 293900,
          "text": "Distal convoluted tubule"
        }
      ],
      "text": "A 55-year-old man presents to the OPD for followup visit, he has congestive heart failure and has been taking a loop diuretic to reduce peripheral edema. His labs reveal a serum potassium of 3.1 mEq/L, so a potassium-sparing diuretic, triamterene, is added to his regimen. Which of the following is the site of action of this agent",
      "unique_key": "Q8255322",
      "question_audio": null,
      "question_video": null,
      "map_id": 34150505,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Potassiumsparing diuretics such as triamterene or amiloride are commonly used in combination with more potent potassium-wasting diuretics (e.g., loop diuretics) to offset their effects on serum potassium. Potassium is lost in the urine when high amounts of sodium pass through the distal convoluted tubule (as is the case with potassium-wasting diuretics) because of a sodium-potassium exchange pump on the distal tubule cells. Triamterene and amiloride inhibit this pump, leaving sodium in the urine and potassium in the blood. Loop diuretics such as furosemide work by inhibiting the Na1/K1/Cl22 transporter on the ascending limb of the loop of Henle. Antidiuretic hormone (ADH) works on the collecting tubule by causing preformed aquaporins to be inserted on the apical membrane of the tubular cells, allowing water to leave the urine back into the blood.<p><img src=\"https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/2(474).jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 293900,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69557701700305753/69557701700305753.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/69557701700305753/69557701700305753.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 85196,
      "choices": [
        {
          "id": 293901,
          "text": "Angiotensin II receptor blockers (ARBs)"
        },
        {
          "id": 293902,
          "text": "Thiazide diuretics"
        },
        {
          "id": 293903,
          "text": "ACE inhibitors"
        },
        {
          "id": 293904,
          "text": "Beta-blockers"
        }
      ],
      "text": "A 68-year-old man with a history of ischemic heart disease and hypertension is prescribed a new medication for his high blood pressure. After a few weeks, he develops symptoms of severe dizziness and syncope upon standing. Which class of antihypertensive drugs is most likely responsible for these symptoms?",
      "unique_key": "Q9808034",
      "question_audio": null,
      "question_video": null,
      "map_id": 34271513,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Thiazide diuretics. Thiazide diuretics, such as hydrochlorothiazide (HCTZ) and chlorthalidone, are commonly prescribed for hypertension, especially in elderly patients. They work by inhibiting sodium reabsorption in the distal convoluted tubule, leading to increased diuresis (fluid loss), reduced blood volume, and lower blood pressure. However, excessive diuresis can cause hypotension, dehydration, and electrolyte imbalances (e.g., hypokalemia, hyponatremia), leading to orthostatic hypotension (a sudden drop in blood pressure upon standing), dizziness, and syncope. This effect is more pronounced in elderly patients and those with preexisting cardiovascular conditions, making them more susceptible to falls and fainting. Explanation of Incorrect Options: (A) Angiotensin II Receptor Blockers (ARBs) – Incorrect. ARBs (e.g., losartan, valsartan) lower blood pressure by blocking angiotensin II receptors, leading to vasodilation and reduced aldosterone secretion. While ARBs can cause hypotension, they rarely cause severe orthostatic hypotension because they do not significantly affect intravascular volume. They are generally well tolerated and are preferred in patients who cannot take ACE inhibitors. (C) ACE Inhibitors – Incorrect. ACE inhibitors (e.g., enalapril, lisinopril) work by blocking the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced blood pressure. Although hypotension can occur, it is more common in patients with volume depletion (e.g., heart failure, diuretics) or those taking their first dose (first-dose hypotension). However, ACE inhibitors do not typically cause significant orthostatic hypotension compared to diuretics. (D) Beta-Blockers – Incorrect. Beta-blockers (e.g., metoprolol, atenolol) lower blood pressure by reducing heart rate and myocardial contractility. While they can cause fatigue, bradycardia, and exercise intolerance, they are not a major cause of orthostatic hypotension. In fact, beta-blockers may even help mitigate reflex tachycardia associated with vasodilators. However, non-selective beta-blockers (e.g., propranolol) may contribute to postural dizziness in some patients.",
      "correct_choice_id": 293902,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23020121727681028/23020121727681028.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/23020121727681028/23020121727681028.m3u8",
      "question_images": [],
      "explanation_images": []
    }
  ]
}